Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of a class of anti-cancer agents. The company designs and develops a chemical molecule that provides dual action on both cancer cell proliferation and change in identity.
You’re viewing a free company profile from the PitchBook Platform. To explore PhenoSwitch Bio’s full profile, request a free trial.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.